Octopus^® Evolution Tissue Stabilizer
Best in Class

The Octopus^® Evolution Stabilizer provides enhanced stability and flexibility featuring:

Greater flexibility provides unlimited positioning options

New Clinical Evidence Supports OPCAB

With hundreds of papers written over the years illustrating the advantages of OPCAB surgery, perhaps none are more compelling than the most recent evidence which includes the 2004 ISMICS Consensus data.

This and other major meta-analyses^2-4 reveal the significant benefits of performing OPCAB (off-pump coronary artery bypass) over CCABG (conventional coronary artery bypass) for certain patient populations requiring myocardial revascularization procedures.^1-4 These studies conclude that OPCAB should be considered as a safe alternative to conventional bypass surgery as it effectively reduces perioperative mortality, morbidity and resource utilization in high-risk and mixed risk patients.¹

In addition, OPCAB surgery can reduce the need for inotropes, documents lower risk for women and is more effective therapy for the older patient and patients with renal disease.

Comparison of OPCAB vs CCABG Outcomes^1-4

Table Represents Summary of Key Journal Articles

[+] Click to enlarge chart

The Octopus Evolution tissue stabilizer is designed to allow you to achieve even better results during OPCAB procedures.

Octopus^® Evolution Tissue Stabilizer — 10th Generation
Demonstrating Medtronic's enduring commitment to cardiac surgery

For more information, contact your local Medtronic Cardiac Surgery Technologies Sales Representative, call Customer Service toll-free at 1-800-328-1357, or contact us.

References:

1. Puskas J, Cheng D, Knight J, Angelini G, DeCannier A, Dullum M, Martin J, Ochi M, Patel N, Sim E, Trehan N, Zamvar V. Offpump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement form the 2004 ISMICS Consensus Conference. Innovations. 2005; 1: 3-27.

2. Mack MJ, Brown P, Houser F, Katz M, Kugelmass A, Simon A , Battaglia S, Tarkingon L, Culler S, Becker E. On-pump versus off-pump coronary artery bypass surgery in a matched sample outcome of women. A comparison of outcomes. Circulation. 2004; 110, (suppl II):II-1-II-6.

3. Reston JT, Tregear SJ, Turkelson CM. Meta-analysis of shortterm and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg. 2003; 76:1510-15.

4. Cheng DC, Bainbridge D, Martin JE, Novick RJ, The Evidencebased Perioperative Outcomes Research Group. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. 2005; 102:188-203.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For a listing of indications, contraindications, precautions and warnings, please refer to the Directions for Use.